白藜芦醇软胶囊对糖尿病患者血糖及早期视网膜病变的疗效观察

张娴, 刘莉

武警医学 ›› 2016, Vol. 27 ›› Issue (8) : 806-809.

PDF(733 KB)
PDF(733 KB)
武警医学 ›› 2016, Vol. 27 ›› Issue (8) : 806-809.
论著

白藜芦醇软胶囊对糖尿病患者血糖及早期视网膜病变的疗效观察

  • 张娴1, 刘莉2
作者信息 +

Effects of resveratrol soft capsules on diabetic patients’s blood sugar and early retinopathy

  • ZHANG Xian1, and LIU Li2
Author information +
文章历史 +

摘要

目的 观察白藜芦醇软胶囊对糖尿病患者血糖及早期视网膜病变的疗效。方法 采用数字表法随机将60例糖尿病早期视网膜病变患者分为A、B、C、D 4组:每组15例, 前3组均在基础治疗上加白藜芦醇软胶囊,其中A组:250 mg/次,口服,2次/d;B组:350 mg/次,口服,2次/d;C组:500 mg/次,口服,2次/d,治疗12周。D组为对照组(基础治疗:运动干预、饮食控制、胰岛素及口服降糖药),比较治疗前后1、8、10、12周末对早期视网膜病变患者的空腹血糖、糖化血红蛋白(hemoglobinA1c,HbALc)、胰岛素进行比较;并在用药前及12周末,采用视网膜荧光造影(fundus fluorescence angiography,FFA)对患者的微血管瘤数、出血灶和渗出灶面积变化进行比较。结果 C组治疗前后比较,空腹血糖:(8.6±0.812)mmol/ L比(6.7±0.714) mmol/L,t=4.752,P=0.033;HbALc:(8.7±0.341)%比(7.2±0.426) %,t=5.542,P=0.031;胰岛素:(32.4±0.342) pmol/ml比(28.3±0.123) pmol/ml,t=6.459,P=0.038;降血糖有效率为66.76%。治疗后C组与D组微血管瘤数、出血灶面积、渗出灶面积均数分别为(16.86±1.75) 个比(10.06±1.29) 个,t=4.624, P<0.05;(2.24±0.23) mm2比(1.45±0.22) mm2,t=2.532, P<0.05;(1.40±0.15) mm2比(1.01±0.23) mm2,t=2.605, P<0.05;治疗后微血管瘤数减少,出血灶面积和渗出灶面积缩小。结论 白藜芦醇软胶囊对糖尿病患者血糖及早期视网膜病变的疗效呈剂量依赖性,其改善糖尿病患者的血糖及早期视网膜病变有效率C组优于B组,B组优于A、D组。

Abstract

Objective To study the efficacy of resveratrol soft capsules on fasting blood glucose and early diabetic retinopathy(DR).Methods 60 diabetic patients with DR were randomly divided into 4 groups: A, C, B and D by using digital table method.15 cases in each group.The first three groups received basic treatment plus resveratrol soft capsules, Group A: 250 mg/ead time, orally, twice/day; Group B: 350 mg/each times, orally,twice/day; Group C: 500 mg/each time, orally, twice/day for 12 weeks. D group was the control group (basic treatment: exercise intervention, diet control, insulin and oral hypoglycemic agents), compared before and after treatment 1,8,10,12 weekend DR fasting glucose.And before medication and 12 weeks,retinal fluorescein angiography (fundus fluorescence angiography FFA) was used to detect microvascular changes in the patient’s capillary hemangioma,hemorrhage and leakage area for comparison.Results In C group,after treatment ,FPG(8.6±0.812)mmol/L ratio(6.7±0.714)mmol/L,t=4.752,P=0.037;HbALc:(8.7±0.341)% versus(7.2±0.426)%,t=5.542,P=0.031,ISN:(32.4 ± 0.341)pmol/ml versus (28.3±0.132) pmol/ml,t=6.459,P=0.038,In after group C and D, capillary hemangioma, hemorrhage focal area and leaking focal area were (16.86±1.75)N versas (10.06±1.29)N,t=4.624, P<0.05;(2.24±0.23)mm2 versas(1.45±0.22) mm2,t=2.532, P<0.05,(1.40±0.15) mm2 versas(1.01±0.23) mm2,t=2.605, P<0.05.After treatment, the number of capillary hemangioma was decreased, the area of hemorrhage and the area of leakage were reduced.Conclusions The effect of resveratrol on blood glucose and early retinopathy in diabetic patients is dose dependent,and the effective rate in group C is better than that in group B, and group B was better than groups A and D.

关键词

白藜芦醇软胶囊 / 空腹血糖 / 糖尿病早期视网膜病变

Key words

resveratrol soft capsules / fasting plasma glucose / early diabetic retinopathy

引用本文

导出引用
张娴, 刘莉. 白藜芦醇软胶囊对糖尿病患者血糖及早期视网膜病变的疗效观察[J]. 武警医学. 2016, 27(8): 806-809
ZHANG Xian, and LIU Li. Effects of resveratrol soft capsules on diabetic patients’s blood sugar and early retinopathy[J]. Medical Journal of the Chinese People Armed Police Forces. 2016, 27(8): 806-809
中图分类号: R774.1   

参考文献

[1] 惠延年,王 琳.糖尿病视网膜病变和黄斑水肿的国际临床分类法[J].国际眼科杂志,2004,4(5):56-59.
[2] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京: 中国医学科技出版社,2002:99-104.
[3] 李青春,李 岱.白藜芦醇对眼部疾病防治机制的研究进展[J]. 实用医学杂志,2014,30(24):4044-4046.
[4] Williams R,Airey M,Baxter H,et al.Epidemiology of diabetic retinopathyand and macular oedema:a systematic review[J]. Eye,2004,18(10) :963-983.
[5] Xia N,Daiber A,Habermeier A,et al. Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice[J]. J Pharmacol Exp Ther,2010,335(1):149-154.
[6] 孔祥菊,赵 璐,李国强.白藜芦醇降低妊娠期糖尿病大鼠血糖的作用及机制研究[J].哈尔滨医科大学学报,2014,8(48):286-287.
[7] 张皎月,陈璐璐,郑 涓,等.白藜芦醇改善高脂饲养小鼠胰岛功能的观察[J].中国糖尿病杂志,2013,6,(21):551-553.
[8] Lee J H,Song M Y,Song E K,et al.Overexpression of SIRT1 protects pancreatic betta-cells against cytokine toxicity by suppressing the nuclearfactor-kappaB signaling pathway[J].Diabetes,2009,58(2):344-351.
[9] Um J H,Park S J,Kang H,et al.AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol[J].Diabetes,2010,59(3):554-563.
[10] Wan T T,Li X F,Sun Y H, et al.Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy[J].Biomed Pharmacother,2015,74(1):145-147.

基金

云南省昆明市西山区基金课题项目(西-2014012)


PDF(733 KB)

Accesses

Citation

Detail

段落导航
相关文章

/